Clinical trial
Clinical Outcomes of Endovenous Laser Ablation With 1940 nm Versus 1470 nm for the Treatment of Varicose Veins [ Randomized Controlled Trial]
NCT07603570 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes of Endovenous Laser Ablation With 1940 nm Versus 1470 nm for the Treatment of Varicose Veins [ Randomized Controlled Trial]
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- September 1, 2025
- Completion date
- September 1, 2026
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
great saphenous vein (gsv) with venous reflux disease, varicose veins of lower limb